BioAtla Combines EpiVax, Inc.'s Immunogenicity Screening Into Their Express Humanization™ Platform
4/24/2013 11:14:03 AM
More...
|
EpiVax, Inc.-Novozymes Biopharma Tregitope-Albumin Fusion Moves "Paradigm-Shifting" Treatment for Diabetes Closer to Clinical Trials
2/12/2013 9:23:05 AM
More...
|
Funding for Orphan Disease Indication Will Compare EpiVax, Inc.'s Tregitope with IVIG
11/19/2012 10:08:25 AM
More...
|
EpiVax, Inc. Research on Tregitopes Wins 2010 AAPS Innovation in Biotechnology Award
5/25/2010 3:20:19 PM
More...
|
EpiVax, Inc. Tregitope Technology: a Paradigm Shift
3/3/2010 1:02:25 PM
More...
|
EpiVax, Inc. Receives National Institutes of Health (NIH) Grant for $390,000 to Optimize HIV Vaccine Delivery
12/1/2008 9:20:24 AM
More...
|
EpiVax, Inc. Receives $600,000 Grant to Develop Treatment for Diabetes from National Institutes of Health (NIH)
7/8/2008 8:42:53 AM
More...
|
Rhode Island Biotech EpiVax, Inc. Receives $500K Federal Grant to Reengineer FVIII using ''Immunoinformatics''
6/27/2007 12:52:20 PM
More...
|
Rhode Island Biotechnology Company EpiVax, Inc. Receives $ 368K Federal Grant to Reengineer Botulinum Toxin Using ''Immunoinformatics''
2/28/2007 12:13:32 PM
More...
|
Rhode Island Biotechnology Company EpiVax, Inc. Develops Tularemia Vaccine
1/31/2007 11:57:25 AM
More...
|
|